Guidance on the implementation of decentralised elements in clinical trials with medicinal products is now available
Guidance on the implementation of decentralised elements in clinical trials with medicinal products is now available: Decentralised clinical trials with medicinal products meet the patients, wherever they are, in a faster and more efficient process benefitting both patient, healthcare professionals and industry. It is therefore gratifying to be able to announce that another important milestone […]Continue reading